- Diseases
- Acoustic Neuroma (14)
- Adrenal Gland Tumor (24)
- Anal Cancer (66)
- Anemia (2)
- Appendix Cancer (16)
- Bile Duct Cancer (28)
- Bladder Cancer (68)
- Brain Metastases (28)
- Brain Tumor (228)
- Breast Cancer (710)
- Breast Implant-Associated Anaplastic Large Cell Lymphoma (2)
- Cancer of Unknown Primary (4)
- Carcinoid Tumor (8)
- Cervical Cancer (154)
- Colon Cancer (164)
- Colorectal Cancer (110)
- Endocrine Tumor (4)
- Esophageal Cancer (42)
- Eye Cancer (36)
- Fallopian Tube Cancer (6)
- Germ Cell Tumor (4)
- Gestational Trophoblastic Disease (2)
- Head and Neck Cancer (4)
- Kidney Cancer (124)
- Leukemia (344)
- Liver Cancer (50)
- Lung Cancer (288)
- Lymphoma (284)
- Mesothelioma (14)
- Metastasis (30)
- Multiple Myeloma (98)
- Myelodysplastic Syndrome (60)
- Myeloproliferative Neoplasm (4)
- Neuroendocrine Tumors (16)
- Oral Cancer (98)
- Ovarian Cancer (172)
- Pancreatic Cancer (166)
- Parathyroid Disease (2)
- Penile Cancer (14)
- Pituitary Tumor (6)
- Prostate Cancer (144)
- Rectal Cancer (58)
- Renal Medullary Carcinoma (6)
- Salivary Gland Cancer (14)
- Sarcoma (234)
- Skin Cancer (294)
- Skull Base Tumors (54)
- Spinal Tumor (12)
- Stomach Cancer (60)
- Testicular Cancer (28)
- Throat Cancer (90)
- Thymoma (6)
- Thyroid Cancer (98)
- Tonsil Cancer (30)
- Uterine Cancer (78)
- Vaginal Cancer (14)
- Vulvar Cancer (18)
- Cancer Topic
- Adolescent and Young Adult Cancer Issues (20)
- Advance Care Planning (10)
- Biostatistics (2)
- Blood Donation (18)
- Bone Health (8)
- COVID-19 (362)
- Cancer Recurrence (120)
- Childhood Cancer Issues (120)
- Clinical Trials (620)
- Complementary Integrative Medicine (22)
- Cytogenetics (2)
- DNA Methylation (4)
- Diagnosis (224)
- Epigenetics (6)
- Fertility (62)
- Follow-up Guidelines (2)
- Health Disparities (14)
- Hereditary Cancer Syndromes (122)
- Immunology (18)
- Li-Fraumeni Syndrome (8)
- Mental Health (116)
- Molecular Diagnostics (8)
- Pain Management (64)
- Palliative Care (8)
- Pathology (10)
- Physical Therapy (18)
- Pregnancy (18)
- Prevention (880)
- Research (384)
- Second Opinion (74)
- Sexuality (16)
- Side Effects (596)
- Sleep Disorders (10)
- Stem Cell Transplantation Cellular Therapy (216)
- Support (404)
- Survivorship (324)
- Symptoms (182)
- Treatment (1762)
Why I chose MD Anderson for skull base tumor treatment
3 minute read | Published February 24, 2020
Medically Reviewed | Last reviewed by an MD Anderson Cancer Center medical professional on February 24, 2020
Until a few years ago, my father was the only person in my family who’d ever had cancer. In 1997, he was diagnosed with mesothelioma, which is almost always caused by exposure to asbestos.
My dad developed the disease in his lungs after working in the electrical services industry for 20 years. By the time he was diagnosed, the cancer had already spread to his brain. My father died of complications of mesothelioma in 1999, at age 50.
I’ve worked in health and education for most of my professional life, so as far as I know, I’ve never been exposed to asbestos. I never thought I’d receive a cancer diagnosis of my own. But life can change in a moment. Mine did in October 2017.
My skull base tumor diagnosis
I’d been seeing my family doctor for about nine months to treat what I thought was a stubborn sinus infection. But it kept getting worse, even after several rounds of antibiotics and oral steroids. I couldn’t breathe out of the right side of my nose. I was getting bad headaches, too.
My doctor referred me to an ear, nose and throat specialist. He ordered a CT scan and an MRI, which showed a growth in my sinus cavity. The next day, he ordered a biopsy.
It took two and a half weeks and several different medical labs to get a concrete diagnosis. When the results finally came back, my ENT gave me the news: I had esthesioneuroblastoma, also known as olfactory neuroblastoma. It’s a rare type of skull base tumor that starts in the sinus cavity and grows toward the brain.
- Related topic: Skull base tumor symptoms
Choosing MD Anderson for skull base tumor treatment
A skull base tumor diagnosis was a lot to digest. I felt scared, especially since my cancer was so unusual. I was also pretty worried and unsure about what my treatment would entail.
But I knew that I wanted to go to MD Anderson for my skull base tumor treatment. It has a reputation as a highly regarded cancer hospital. And I knew its doctors would have experience with my specific type of cancer, which was important. So I made an appointment, then made the trip from Missouri to Houston.
Life after a skull base tumor
At MD Anderson, we met with sinus and skull base tumor surgeon Dr. Shirley Su and radiation oncologist Dr. Clifton Fuller. They recommended surgery to remove the tumor, followed by 32 radiation therapy treatments. Dr. Su explained that the entire procedure would be performed through the nose and I would have no external scars. She performed the surgery on Nov. 20, 2017. I started my radiation treatments in January 2018, and finished the following month. I’ve shown no evidence of disease since then.
I experience some dry mouth now, and I have no sense of smell anymore. My thyroid was a little damaged by the radiation, too, so I’m taking medication for that. And I have to rinse my sinuses a couple of times a day with a saline solution. But other than that, my life is pretty much back to normal. I work full time and play golf and just try to make the most of every day.
Cancer changes your life. But MD Anderson does an exceptional job of treating each and every patient as a valuable human being with a life worth saving. So, I wouldn’t go anywhere else.
Request an appointment at MD Anderson online or by calling 1-844-752-0512.

I wouldn’t go anywhere else.
Kevin Thurman
Survivor